🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Status
Completed
Location
L-MARC Research Center
Start Date
2017-04-07
Trial ID
NCT03193047
Treatments Being Tested
The primary objective was to evaluate the effect of 12 weeks of subcutaneou...
Status
Completed
Location
Research Site
Start Date
2013-01-24
Trial ID
NCT01763905
Treatments Being Tested
Patients diagnosed with moyamoya vasculopathy by imaging and classified as ...
Status
Not Yet Recruiting
Location
180 Fenglin Road, Xuhui District, Shanghai 200032,China
Start Date
2025-12-30
Trial ID
NCT07286110
Treatments Being Tested
To evaluate the effect of 12 weeks of subcutaneous (SC) evolocumab (AMG 145...
Status
Completed
Location
Research Site
Start Date
2011-07-01
Trial ID
NCT01380730
Treatments Being Tested
Evolocumab is a monoclonal antibody that inhibits proprotein convertase sub...
Status
Unknown
Location
Policlinico Casilino
Start Date
2020-05-04
Trial ID
NCT04397653
Treatments Being Tested
The primary objective of the study was to evaluate the effect of 12 weeks o...
Status
Completed
Location
Research Site
Start Date
2016-02-27
Trial ID
NCT02634580
Treatments Being Tested
The primary objective of this study was to evaluate the effect of 12 weeks ...
Status
Completed
Location
Research Site
Start Date
2016-04-14
Trial ID
NCT02662569
Treatments Being Tested
The primary objective was to evaluate the effect of 12 weeks of evolocumab ...
Status
Completed
Location
Research Site
Start Date
2013-02-07
Trial ID
NCT01763918
Treatments Being Tested
Clopidogrel is the most widely used P2Y12 receptor inhibitor and is the onl...
Status
Completed
Location
University of Florida
Start Date
2017-10-03
Trial ID
NCT03096288
Treatments Being Tested
Peripheral arterial disease (PAD) is a manifestation of systemic atheroscle...
Status
Unknown
Location
University of Southern California
Start Date
2017-12-14
Trial ID
NCT04306081